These two trials build on previous studies with BIT225 for treatment of HIV. Once again BIT225 was found to have statistically significant impact on important immune and inflammation biomarkers.
These positive results are important as they provide further evidence that BIT225 is acting in a unique way against HIV.
Current anti-HIV drugs (also known as antiretroviral treatment or ART) have come a long way since the early days of AIDS. However, while ART is generally very effective at stopping replication of the virus, these existing drugs have no impact on reservoirs of HIV that are laid down early in infection and cannot be cleared out with ART.
Did we see any such changes? Yes – statistically significant changes were seen in several immune biomarkers during the 12 weeks on BIT225/ART treatment compared to before starting on BIT225 i.e. when on ART alone.
This Technology has value ,,,, the question is can this current Management Team locate the Treatments Optimum Customer? NZT
BIT Price at posting:
3.6¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)